Fierce Biotech Homepage

Orange flag on top of a mountain
Pharma

FDA approves Denali's Hunter syndrome drug

In approving Avlayah, the FDA has greenlit the first treatment for Hunter syndrome that addresses the condition’s pernicious cognitive symptoms.
Darren Incorvaia Mar 25, 2026 2:50pm
Takeda

Takeda targets $1.3B in savings with new efficiency drive

Mar 25, 2026 10:44am
NVS

Novartis pledges nearly $480M to bolster China production, R&D

Mar 23, 2026 10:35am
FDA

FDA solicits feedback on national priority voucher pilot

Mar 23, 2026 9:35am
AstraZeneca

AZ to build cell therapy supply hub, R&D center in Shanghai

Mar 19, 2026 10:20am
liver
Favicon Fierce Biotech

BioVie plans $20M IPO for spinout developing liver disease drug

Mar 17, 2026 5:18am
More News

Idorsia shares sink after CEO's abrupt departure

Mar 16, 2026 11:00am
Fierce Biotech

Building BLOC: Meet Biopharma Leaders of Color

Mar 12, 2026 10:00am

FDA approves leucovorin without clinical trial—but not for autism

Mar 10, 2026 9:00am
Fierce Biotech

BioNTech's CEO, CMO will depart to set up next-gen mRNA company

Mar 10, 2026 6:30am